A federal stop-work order has threatened the progress a Weill Cornell Medicine researcher has made in understanding a lethal and treatment-resistant form of prostate cancer.
Investigators at Weill Cornell Medicine and Cornell’s Ithaca campus will use a $5.1 million grant from the NIH to launch the Autism Replication, Validation, and Reproducibility Center, which aims to improve the reliability of autism research.
Most health policy experts don’t think new Medicaid work requirements introduced in the One Big Beautiful Bill Act (OBBBA) would substantially increase employment among Medicaid-enrolled, working-age adults, according to a new survey from the Cornell Health Policy Insight Panel.
Drawing on cutting-edge technology and interdisciplinary expertise, researchers are launching Menopause Health Engineering, a new initiative to uncover how menopause shapes health and disease.
“Kangaroo care,” or skin-to-skin contact, may be neuroprotective and is associated with neonatal development in areas of the brain involved in emotional regulation in preterm infants, according to a new preliminary study.
Weill Cornell Medicine is collaborating with colleagues in Tanzania to increase the pipeline of female doctors, researchers and policymakers in health care, and focus attention on women’s health in Tanzania.
Increased risk for anxiety may begin before birth, shaped by infection or stressful events during pregnancy, according to a new study from researchers at Weill Cornell Medicine.
Patients taking an experimental oral GLP-1 drug lost significant weight and improved heart and metabolic risk factors in a large, international phase III clinical trial.
